Detailed answers about CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED, including incorporation, status, business activity, and accounts information.
When was CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED founded?
CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED was officially incorporated on 3 September 1971 and is registered under company number 01023065. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED?
CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED do?
CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED operates in the following sector: 74990 - Non-trading company. This provides insight into the company's primary business activity and industry focus.
What is CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED's registered address?
The registered office address of CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED is ONE FLEET HOUSE, LONDON, UNITED KINGDOM, EC4M 7WS. This is the official address filed with Companies House for legal and statutory correspondence.
Is CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED financially stable?
The most recent accounts for CONCEPT PHARMACEUTICALS (INTERNATIONAL) LIMITED were made up to 30 April 2025, filed as DORMANT. Next accounts are due by 31 January 2027.